# | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
---|---|---|---|---|---|---|---|---|---|
1. | ALA990854 | A | Half life in iv dosed baboon thalamus | Papio anubis | 5 | organism-based format | Scientific Literature | ||
2. | ALA1025730 | F | In vivo binding affinity to amyloid beta (1 to 40) peptide in ovariectomized baboon by SPECT imaging | Papio anubis | 1 | organism-based format | Scientific Literature | ||
3. | ALA1219611 | F | Antithrombotic activity in Baboon deep vein thrombosis model assessed as vein opening at 1 mg/kg, po | Papio anubis | 1 | organism-based format | Scientific Literature | ||
4. | ALA1219612 | F | Antithrombotic activity in Baboon deep vein thrombosis model assessed as decrease in vein wall inflammation at 1 mg/kg, po | Papio anubis | 1 | organism-based format | Scientific Literature | ||
5. | ALA1219613 | T | Toxicity in in Baboon deep vein thrombosis model assessed as induction of coagulation at 1 mg/kg, po | Papio anubis | 1 | organism-based format | Scientific Literature | ||
6. | ALA2416503 | A | Drug metabolism in baboon at 111 +/- 18 MBq, iv after 2 to 180 mins | Papio anubis | 1 | organism-based format | Scientific Literature | ||
7. | ALA3532373 | A | Drug level in baboon plasma assessed as radioactivity treated with [18F]DPA714 measured after 30 to 120 mins by radio-HPLC analysis relative to total radioactivity | Papio anubis | 1 | organism-based format | Scientific Literature | ||
8. | ALA3535309 | A | Drug recovery in baboon by SPE method | Papio anubis | 1 | organism-based format | Scientific Literature | ||
9. | ALA3535311 | A | Half life in baboon by SPE method | Papio anubis | 1 | organism-based format | Scientific Literature | ||
10. | ALA3535312 | A | Half life in baboon by radio-HPLC analysis | Papio anubis | 1 | organism-based format | Scientific Literature | ||
11. | ALA3535315 | A | Drug metabolism in baboon assessed as compound remaining measured at 30 mins by radio-HPLC analysis | Papio anubis | 1 | organism-based format | Scientific Literature | ||
12. | ALA3535316 | A | Drug metabolism in baboon assessed as compound remaining measured at 120 mins by radio-HPLC analysis | Papio anubis | 1 | organism-based format | Scientific Literature | ||
13. | ALA3591364 | A | In vivo occupancy at dopamine D3 receptor in Papio anubis at 1 mg/kg, po by PET imaging method | Papio anubis | 1 | organism-based format | Scientific Literature | ||
14. | ALA3591365 | A | In vivo occupancy at dopamine D3 receptor in Papio anubisat 3 mg/kg, po by PET imaging method | Papio anubis | 1 | organism-based format | Scientific Literature | ||
15. | ALA4039305 | F | In vivo receptor occupancy at mGlu5 in baboon at 0.56 mg/kg, iv administered over 20 mins for 30 mins prior to [18F]-FPEB addition by microPET imaging analysis | Papio anubis | 1 | organism-based format | Scientific Literature | ||
16. | ALA4039306 | F | In vivo receptor occupancy at mGlu5 in baboon assessed as total plasma concentration required to show 50% effect up to 0.56 mg/kg, iv administered over 20 mins for 30 mins prior to [18F]-FPEB addition by microPET imaging analysis | Papio anubis | 1 | organism-based format | Scientific Literature | ||
17. | ALA4039307 | F | In vivo receptor occupancy at mGlu5 in baboon assessed as unbound plasma concentration required to show 50% effect up to 0.56 mg/kg, iv administered over 20 mins for 30 mins prior to [18F]-FPEB addition by microPET imaging analysis | Papio anubis | 1 | organism-based format | Scientific Literature | ||
18. | ALA4039308 | F | In vivo receptor occupancy at mGlu5 in iv dosed baboon administered over 20 mins of 30 mins prior to [18F]-FPEB addition by microPET imaging analysis | Papio anubis | 1 | organism-based format | Scientific Literature |